What is the current annual EBITDA of GMED?

As of today, GMED annual EBITDA is $818.24M

What is 1-year change in GMED annual EBITDA?

GMED annual EBITDA is up +68.25% year-over-year

What is 3-year change in GMED annual EBITDA?

GMED annual EBITDA is up +168.58% over the past 3 years

How far is GMED annual EBITDA from its all-time high?

GMED annual EBITDA is currently at its all-time high

How does GMED annual EBITDA rank versus sector peers?

GMED annual EBITDA is higher than 92.54% of companies in Healthcare sector

When is GMED next annual earnings release?

As of today, the next annual earnings release for GMED has not been scheduled

What is the current quarterly EBITDA of GMED?

As of today, GMED quarterly EBITDA is $251.28M

What is GMED quarterly EBITDA most recent change?

GMED quarterly EBITDA was up +22.09% on December 31, 2025

What is 1-year change in GMED quarterly EBITDA?

GMED quarterly EBITDA is up +59.14% year-over-year

How far is GMED quarterly EBITDA from its all-time high?

GMED quarterly EBITDA is currently at its all-time high

How does GMED quarterly EBITDA rank versus sector peers?

GMED quarterly EBITDA is higher than 92.62% of companies in Healthcare sector

When is GMED next earnings release?

The next earnings release for GMED is on May 7, 2026

What is the current TTM EBITDA of GMED?

As of today, GMED TTM EBITDA is $818.24M

What is GMED TTM EBITDA most recent change?

GMED TTM EBITDA was up +12.88% on December 31, 2025

What is 1-year change in GMED TTM EBITDA?

GMED TTM EBITDA is up +64.00% year-over-year

How far is GMED TTM EBITDA from its all-time high?

GMED TTM EBITDA is currently at its all-time high

How does GMED TTM EBITDA rank versus sector peers?

GMED TTM EBITDA is higher than 91.98% of companies in Healthcare sector

When is GMED next earnings release?

The next earnings release for GMED is on May 7, 2026

GMED EBITDA History & Chart Since 2009

Annual EBITDA

$818.24M$331.90M+68.25%

December 31, 2025

Summary

Current Value: As of today, GMED annual EBITDA is $818.24M, up +68.25% on December 31, 2025
Historical Performance: GMED annual EBITDA is up +168.58% over the past 3 years, up +303.54% over the past 5 years
All-Time High Comparison: GMED annual EBITDA is currently at its all-time high
3-Year Low Comparison: GMED annual EBITDA is +168.58% above its 3-year low of $304.65M reached on an earlier date
Sector Comparison: GMED annual EBITDA is higher than 92.54% of companies in Healthcare sector

EBITDA Chart

Add series to chart

Add series to chart1/6

Company, ETF, index, screener or watchlist

Series

Performance

GMED Performance
Metric	Date	Value	1Y	3Y	5Y	15Y
Annual EBITDA	Dec 31, 25	$818.24M	+68.3%	+168.6%	+303.5%	+674.4%
Quarterly EBITDA	Dec 31, 25	$251.28M	+59.1%	+218.6%	+224.6%	+825.6%
TTM EBITDA	Dec 31, 25	$818.24M	+64.0%	+168.6%	+303.6%	+2914.1%
Price	Mar 6, 26	$87.10	+14.1%	+47.1%	+40.2%	–
PE Ratio	Mar 6, 26	22.14	-78.4%	-30.7%	-64.3%	–
Annual Revenue	Dec 31, 25	$2.94B	+16.6%	+187.3%	+272.5%	+919.8%
Annual EPS	Dec 31, 25	$3.92	+425.4%	+111.8%	+287.4%	+554.1%
	Dec 31, 25	$540.76M	+132.8%	+128.8%	+286.6%	+497.7%
Annual Net Income	Dec 31, 25	$537.87M	+422.3%	+182.8%	+425.9%	+887.7%

EBITDA Highs

GMED Annual EBITDA Highs Comparison
Period	High	Date	Current
3Y	$818.24M	Dec 31, 25	at high
5Y	$818.24M	Dec 31, 25	at high
All	$818.24M	Dec 31, 25	at high

EBITDA Lows

GMED Annual EBITDA Lows Comparison
Period	Low	Date	Current
3Y	$304.65M	N/A	+168.6%
5Y	$202.76M	N/A	+303.5%
All	$97.30M	Dec 31, 09	+741.0%

EBITDA History

Year	Value	Change
2025	$818.24M	+68.2%
2024	$486.34M	+40.3%
2023	$346.58M	+13.8%
2022	$304.65M	+1.9%
2021	$299.04M	+47.5%
2020	$202.76M	-11.6%
2019	$229.49M	+5.0%
2018	$218.51M	+4.7%
2017	$208.70M	+5.5%

Year	Value	Change
2016	$197.89M	-0.8%
2015	$199.42M	+21.1%
2014	$164.65M	+14.1%
2013	$144.25M	+9.2%
2012	$132.12M	+14.1%
2011	$115.78M	+9.6%
2010	$105.67M	+8.6%
2009	$97.30M	-

FAQ

What is the current annual EBITDA of GMED?
As of today, GMED annual EBITDA is $818.24M
What is 1-year change in GMED annual EBITDA?
GMED annual EBITDA is up +68.25% year-over-year
What is 3-year change in GMED annual EBITDA?
GMED annual EBITDA is up +168.58% over the past 3 years
How far is GMED annual EBITDA from its all-time high?
GMED annual EBITDA is currently at its all-time high
How does GMED annual EBITDA rank versus sector peers?
GMED annual EBITDA is higher than 92.54% of companies in Healthcare sector
When is GMED next annual earnings release?
As of today, the next annual earnings release for GMED has not been scheduled

Quarterly EBITDA

$251.28M$45.47M+22.09%

December 31, 2025

Summary

Current Value: As of today, GMED quarterly EBITDA is $251.28M, up +22.09% on December 31, 2025
Historical Performance: GMED quarterly EBITDA is up +59.14% year-over-year, up +218.56% over the past 3 years
All-Time High Comparison: GMED quarterly EBITDA is currently at its all-time high
3-Year Low Comparison: GMED quarterly EBITDA is +231.19% above its 3-year low of $75.87M reached on March 31, 2023
Sector Comparison: GMED quarterly EBITDA is higher than 92.62% of companies in Healthcare sector

Performance

GMED Performance
Metric	Date	Value	3M	1Y	3Y	5Y
Quarterly EBITDA	Dec 31, 25	$251.28M	+22.1%	+59.1%	+218.6%	+224.6%
Annual EBITDA	Dec 31, 25	$818.24M	–	+68.3%	+168.6%	+303.5%
TTM EBITDA	Dec 31, 25	$818.24M	+12.9%	+64.0%	+168.6%	+303.6%
Price	Mar 6, 26	$87.10	-4.4%	+14.1%	+47.1%	+40.2%
PE Ratio	Mar 6, 26	22.14	-24.8%	-78.4%	-30.7%	-64.3%
Quarterly Revenue	Dec 31, 25	$826.42M	+7.5%	+25.7%	+201.1%	+254.0%
Quarterly EPS	Dec 31, 25	$1.03	+17.1%	+442.6%	+110.2%	+97.1%
	Dec 31, 25	$181.63M	+34.9%	+102.6%	+193.1%	+200.2%
Quarterly Net Income	Dec 31, 25	$140.59M	+18.2%	+430.4%	+180.8%	+165.5%

Quarterly EBITDA Highs

GMED Quarterly EBITDA Highs Comparison
Period	High	Date	Current
1Y	$251.28M	Dec 31, 25	at high
3Y	$251.28M	Dec 31, 25	at high
5Y	$251.28M	Dec 31, 25	at high
All	$251.28M	Dec 31, 25	at high

Quarterly EBITDA Lows

GMED Quarterly EBITDA Lows Comparison
Period	Low	Date	Current
1Y	$157.90M	N/A	+59.1%
3Y	$75.87M	Mar 31, 23	+231.2%
5Y	$65.55M	Mar 31, 22	+283.4%
All	$14.19M	Jun 30, 20	+1670.7%

Quarterly EBITDA History

Month	Value	Change
Dec 2025	$251.28M	+22.1%
Sep 2025	$205.81M	+4.5%
Jun 2025	$196.86M	+19.8%
Mar 2025	$164.29M	+4.0%
Dec 2024	$157.90M	+36.2%
Sep 2024	$115.95M	-9.2%
Jun 2024	$127.71M	+31.1%
Mar 2024	$97.39M	+0.3%
Dec 2023	$97.12M	+12.5%
Sep 2023	$86.34M	-4.1%
Jun 2023	$89.99M	+18.6%
Mar 2023	$75.87M	-3.8%
Dec 2022	$78.88M	+2.9%
Sep 2022	$76.63M	-8.3%
Jun 2022	$83.60M	+27.5%
Mar 2022	$65.55M	-15.1%
Dec 2021	$77.23M	+8.7%
Sep 2021	$71.05M	-9.9%
Jun 2021	$78.88M	+9.7%
Mar 2021	$71.89M	-7.1%
Dec 2020	$77.41M	+14.6%
Sep 2020	$67.58M	+376.2%
Jun 2020	$14.19M	-67.4%
Mar 2020	$43.56M	-33.9%
Dec 2019	$65.92M	+14.0%
Sep 2019	$57.82M	+3.6%
Jun 2019	$55.83M	+11.9%
Mar 2019	$49.91M	-18.8%
Dec 2018	$61.46M	+25.3%
Sep 2018	$49.03M	-6.9%

Month	Value	Change
Jun 2018	$52.68M	-4.8%
Mar 2018	$55.35M	-3.7%
Dec 2017	$57.49M	+16.2%
Sep 2017	$49.46M	+1.1%
Jun 2017	$48.93M	-7.6%
Mar 2017	$52.94M	-1.1%
Dec 2016	$53.54M	+14.7%
Sep 2016	$46.68M	-2.7%
Jun 2016	$48.00M	-3.1%
Mar 2016	$49.53M	-2.3%
Dec 2015	$50.71M	+8.4%
Sep 2015	$46.79M	+8.0%
Jun 2015	$43.31M	-2.1%
Mar 2015	$44.23M	-6.1%
Dec 2014	$47.11M	+16.8%
Sep 2014	$40.34M	+5.4%
Jun 2014	$38.26M	-4.5%
Mar 2014	$40.07M	-3.9%
Dec 2013	$41.68M	+21.4%
Sep 2013	$34.33M	-3.2%
Jun 2013	$35.46M	+4.6%
Mar 2013	$33.89M	+0.5%
Dec 2012	$33.73M	+6.4%
Sep 2012	$31.70M	-6.6%
Jun 2012	$33.93M	+3.6%
Mar 2012	$32.75M	-55.3%
Dec 2011	$73.25M	+2.5%
Sep 2011	$71.46M	+5.5%
Jun 2011	$67.72M	+149.5%
Mar 2011	$27.15M	-

FAQ

What is the current quarterly EBITDA of GMED?
As of today, GMED quarterly EBITDA is $251.28M
What is GMED quarterly EBITDA most recent change?
GMED quarterly EBITDA was up +22.09% on December 31, 2025
What is 1-year change in GMED quarterly EBITDA?
GMED quarterly EBITDA is up +59.14% year-over-year
How far is GMED quarterly EBITDA from its all-time high?
GMED quarterly EBITDA is currently at its all-time high
How does GMED quarterly EBITDA rank versus sector peers?
GMED quarterly EBITDA is higher than 92.62% of companies in Healthcare sector
When is GMED next earnings release?
The next earnings release for GMED is on May 7, 2026

TTM EBITDA

$818.24M$93.38M+12.88%

December 31, 2025

Summary

Current Value: As of today, GMED TTM EBITDA is $818.24M, up +12.88% on December 31, 2025
Historical Performance: GMED TTM EBITDA is up +64.00% year-over-year, up +168.58% over the past 3 years
All-Time High Comparison: GMED TTM EBITDA is currently at its all-time high
3-Year Low Comparison: GMED TTM EBITDA is +168.58% above its 3-year low of $304.66M reached on an earlier date
Sector Comparison: GMED TTM EBITDA is higher than 91.98% of companies in Healthcare sector

Performance

GMED Performance
Metric	Date	Value	3M	1Y	3Y	5Y
TTM EBITDA	Dec 31, 25	$818.24M	+12.9%	+64.0%	+168.6%	+303.6%
Annual EBITDA	Dec 31, 25	$818.24M	–	+68.3%	+168.6%	+303.5%
Quarterly EBITDA	Dec 31, 25	$251.28M	+22.1%	+59.1%	+218.6%	+224.6%
Price	Mar 6, 26	$87.10	-4.4%	+14.1%	+47.1%	+40.2%
PE Ratio	Mar 6, 26	22.14	-24.8%	-78.4%	-30.7%	-64.3%
TTM Revenue	Dec 31, 25	$2.94B	+6.1%	+16.6%	+187.3%	+272.5%
TTM EPS	Dec 31, 25	$3.93	+27.1%	+428.5%	+112.2%	+292.4%
	Dec 31, 25	$540.76M	+20.5%	+120.8%	+128.8%	+286.6%
TTM Net Income	Dec 31, 25	$537.87M	+26.9%	+422.3%	+182.8%	+425.9%

TTM EBITDA Highs

GMED TTM EBITDA Highs Comparison
Period	High	Date	Current
1Y	$818.24M	Dec 31, 25	at high
3Y	$818.24M	Dec 31, 25	at high
5Y	$818.24M	Dec 31, 25	at high
All	$818.24M	Dec 31, 25	at high

TTM EBITDA Lows

GMED TTM EBITDA Lows Comparison
Period	Low	Date	Current
1Y	$498.94M	N/A	+64.0%
3Y	$304.66M	N/A	+168.6%
5Y	$202.75M	N/A	+303.6%
All	$27.15M	Mar 31, 11	+2914.1%

TTM EBITDA History

Month	Value	Change
Dec 2025	$818.24M	+12.9%
Sep 2025	$724.86M	+14.2%
Jun 2025	$634.99M	+12.2%
Mar 2025	$565.84M	+13.4%
Dec 2024	$498.94M	+13.9%
Sep 2024	$438.16M	+7.2%
Jun 2024	$408.56M	+10.2%
Mar 2024	$370.84M	+6.2%
Dec 2023	$349.32M	+5.5%
Sep 2023	$331.09M	+3.0%
Jun 2023	$321.37M	+2.0%
Mar 2023	$314.98M	+3.4%
Dec 2022	$304.66M	+0.5%
Sep 2022	$303.00M	+1.9%
Jun 2022	$297.42M	+1.6%
Mar 2022	$292.70M	-2.1%
Dec 2021	$299.04M	-0.1%
Sep 2021	$299.22M	+1.2%
Jun 2021	$295.75M	+28.0%
Mar 2021	$231.07M	+14.0%
Dec 2020	$202.75M	+6.0%
Sep 2020	$191.25M	+5.4%
Jun 2020	$181.50M	-18.7%
Mar 2020	$223.14M	-2.8%
Dec 2019	$229.49M	+2.0%
Sep 2019	$225.02M	+4.1%
Jun 2019	$216.23M	+1.5%
Mar 2019	$213.08M	-2.5%
Dec 2018	$218.51M	+1.8%
Sep 2018	$214.55M	-0.2%

Month	Value	Change
Jun 2018	$214.97M	+1.8%
Mar 2018	$211.22M	+1.2%
Dec 2017	$208.81M	+1.9%
Sep 2017	$204.86M	+1.4%
Jun 2017	$202.08M	+0.5%
Mar 2017	$201.15M	+1.7%
Dec 2016	$197.74M	+1.4%
Sep 2016	$194.91M	-0.1%
Jun 2016	$195.03M	+2.5%
Mar 2016	$190.34M	+2.9%
Dec 2015	$185.04M	+2.0%
Sep 2015	$181.44M	+3.7%
Jun 2015	$174.99M	+3.0%
Mar 2015	$169.94M	+2.5%
Dec 2014	$165.78M	+3.4%
Sep 2014	$160.35M	+3.9%
Jun 2014	$154.34M	+1.8%
Mar 2014	$151.54M	+4.3%
Dec 2013	$145.36M	+5.8%
Sep 2013	$137.41M	+1.9%
Jun 2013	$134.79M	+1.1%
Mar 2013	$133.26M	+0.9%
Dec 2012	$132.12M	-23.0%
Sep 2012	$171.64M	-18.8%
Jun 2012	$211.39M	-13.8%
Mar 2012	$245.18M	+2.3%
Dec 2011	$239.58M	+44.0%
Sep 2011	$166.32M	+75.3%
Jun 2011	$94.87M	+249.5%
Mar 2011	$27.15M	-

FAQ

What is the current TTM EBITDA of GMED?
As of today, GMED TTM EBITDA is $818.24M
What is GMED TTM EBITDA most recent change?
GMED TTM EBITDA was up +12.88% on December 31, 2025
What is 1-year change in GMED TTM EBITDA?
GMED TTM EBITDA is up +64.00% year-over-year
How far is GMED TTM EBITDA from its all-time high?
GMED TTM EBITDA is currently at its all-time high
How does GMED TTM EBITDA rank versus sector peers?
GMED TTM EBITDA is higher than 91.98% of companies in Healthcare sector
When is GMED next earnings release?
The next earnings release for GMED is on May 7, 2026

EBITDA Formula

EBITDA = Net Income + + +

Data Sources & References

GMED Official Website www.globusmedical.com
Most Recent Quarterly Report (10-Q) www.sec.gov/Archives/edgar/data/1237831/000162828026011209/0001628280-26-011209-index.htm
Most Recent Annual Report (10-K) www.sec.gov/Archives/edgar/data/1237831/000162828026011209/0001628280-26-011209-index.htm
GMED Profile on Yahoo Finance finance.yahoo.com/quote/GMED
GMED Profile on NASDAQ.com www.nasdaq.com/market-activity/stocks/gmed